HIV infection and the cardiovascular system

Area of Science:

• Cardiology
• Infectious Diseases
• Oncology

Background:

• Improved HIV treatment prolongs patient survival, leading to increased prevalence of long-term HIV effects.
• Cardiac involvement is frequent in advanced HIV, with common manifestations including dilated cardiomyopathy, myocarditis, and pulmonary hypertension.
• Highly active antiretroviral therapy (HAART) improves survival but does not fully prevent or reverse many HIV-related cardiac sequelae and may increase risks for arterial diseases.

Purpose of the Study:

• To review current knowledge on cardiovascular disease in HIV patients.
• To highlight the importance of early cardiovascular evaluation in HIV management.
• To explore how studying HIV-related cardiovascular disease can inform non-HIV-related cardiovascular disease mechanisms.

Main Methods:

• Literature review of recent studies on HIV-associated cardiovascular disease.
• Analysis of autopsy and echocardiography findings in HIV patients.
• Synthesis of information on cardiac manifestations and treatment implications.

Main Results:

• Common cardiac issues in advanced HIV include dilated cardiomyopathy, myocarditis, pulmonary hypertension, pericardial effusion, endocarditis, neoplasms, and drug toxicity.
• Many HIV-related cardiac conditions persist despite HAART.
• HAART may be linked to increased peripheral and coronary artery disease.

Conclusions:

• Cardiovascular complications are a major concern in long-term HIV survivors.
• Regular cardiovascular assessment is vital for early detection and treatment of cardiac issues in HIV patients.
• Research into HIV cardiovascular disease offers insights into broader cardiovascular pathology.